Reports
Global Diuretic Drugs Therapy Market: By Product: Thiazide Diuretics Local, Loop Diuretics, Potassium-Sparing Diuretics, Others; By Route of Administration; By Application; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2018-2028); Competitive Landscape; Industry Events and Developments
Global Diuretic Drugs Therapy Market Outlook
The global diuretic drugs therapy market is being aided by the growing antihypertensive drugs market, which reached a value of about USD 28 billion in 2020. The antihypertensive drugs industry is further expected to grow at a CAGR of 2% in the forecast period of 2023-2028 to reach a value of approximately USD 32 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Asia Pacific to Significantly Contribute to the Growth of the Global Market for Diuretic Drugs Therapy
North America accounts for a significant share in the industry owing to the availability of advanced diagnostic facilities, increased health care expenditure, and the growing cases of diuretic anomalies and lifestyle related disorders. Meanwhile, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the increasing government initiatives towards patent exclusivity and the growing investments in new drug applications. Further, the factors like the presence of a large population and the growth of the generic drugs market are also aiding the regional industry. Other regions like Europe and the Middle East and Africa are expected to create significant growth opportunities for the market expansion over the forecast period. This can be attributed to the increasing geriatric population in these regions.
Diuretic Drugs Therapy: Market Segmentation
Diuretic drugs therapy refers to a medical treatment for patients suffering from health conditions like high blood pressure, water retention problems, and heart failure (HF). Diuretics, also known as water pills, are a class of drugs that increase the production and volume of urine by tilting the renal fluid regulation in favour of excretion of water and electrolytes (salt). These drugs are commonly prescribed to treat edema, wherein excess fluid accumulates in the tissues due to various disease states like heart failure, liver cirrhosis, and kidney disease. Diuretics are often used to treat hypertension and regulate blood pressure.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the market is divided into:
- Thiazide Diuretics Local
- Loop Diuretics
- Potassium-Sparing Diuretics
- Calcium Sparing Diuretics
- Osmotic Diuretics
- Low Ceiling Diuretics
- Others
By route of administration, the industry can be bifurcated into:
- Oral
- Intravenous
The different applications of diuretic drugs therapy include:
- Hypertension
- Glaucoma
- Heart Failure
- Kidney Stones
- Others
On the basis of distribution channel, the industry can be categorised into:
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Prevalence of High Blood Pressure and Hypertension to Bolster the Growth of the Global Market for Diuretic Drugs Therapy
The increase in the number of people suffering from blood pressure and hypertension is the major factor contributing to the growth of the diuretic drugs therapy industry. Diuretics are used as the chief therapeutic agents to treat hypertension and are generally the first type of medication prescribed by doctors to control blood pressure. According to estimates, worldwide deaths due to high blood pressure are expected to increase from 7.5 million to 1.56 billion by 2026. The market is also being supported by the growing cases of kidney diseases, thus, creating an enhanced demand for drugs like diuretics. The increase in sedentary lifestyles and the changing dietary patterns are one of the major causes of these health conditions. Further, the growing geriatric population and the improving healthcare infrastructures are also contributing to the industry growth. Over the forecast period, the growing R&D activities and the advancements in the field of pharmaceuticals are expected to positively influence the growth of the industry.
Key Industry Players in the Global Diuretic Drugs Therapy Market
The report gives a detailed analysis of the following key players in the global diuretic drugs therapy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Sanofi SA
- Mylan N.V.
- Pfizer Inc.
- Cipla Ltd.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Route of Administration, Application, Distribution Channel, Region |
| Breakup by Product | Thiazide Diuretics Local, Loop Diuretics, Potassium-Sparing Diuretics, Calcium Sparing Diuretics, Osmotic Diuretics, Low Ceiling Diuretics, Others |
| Breakup by Route of Administration | Oral, Intravenous |
| Breakup by Application | Hypertension, Glaucoma, Heart Failure, Kidney Stones, Others |
| Breakup by Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Sanofi SA, Mylan N.V., Pfizer Inc., Cipla Ltd., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Diuretic Drugs Therapy Market Analysis
8.1 Key Industry Highlights
8.2 Global Diuretic Drugs Therapy Historical Market (2018-2022)
8.3 Global Diuretic Drugs Therapy Market Forecast (2023-2028)
8.4 Global Diuretic Drugs Therapy Market by Product
8.4.1 Thiazide Diuretics Local
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Loop Diuretics
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Potassium-Sparing Diuretics
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Calcium Sparing Diuretics
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Osmotic Diuretics
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2022)
8.4.5.3 Forecast Trend (2023-2028)
8.4.6 Low Ceiling Diuretics
8.4.6.1 Market Share
8.4.6.2 Historical Trend (2018-2022)
8.4.6.3 Forecast Trend (2023-2028)
8.4.7 Others
8.5 Global Diuretic Drugs Therapy Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Intravenous
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.6 Global Diuretic Drugs Therapy Market by Application
8.6.1 Hypertension
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Glaucoma
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Heart Failure
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Kidney Stones
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Others
8.7 Global Diuretic Drugs Therapy Market by Distribution Channel
8.7.1 Hospital Pharmacies
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Retail Pharmacies
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Online
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Others
8.8 Global Diuretic Drugs Therapy Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Sanofi SA
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Mylan N.V.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Pfizer Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Cipla Ltd.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Diuretic Drugs Therapy Market: Key Industry Highlights, 2018 and 2028
2. Global Diuretic Drugs Therapy Historical Market: Breakup by Product (USD Million), 2018-2022
3. Global Diuretic Drugs Therapy Market Forecast: Breakup by Product (USD Million), 2023-2028
4. Global Diuretic Drugs Therapy Historical Market: Breakup by Route of Administration (USD Million), 2018-2022
5. Global Diuretic Drugs Therapy Market Forecast: Breakup by Route of Administration (USD Million), 2023-2028
6. Global Diuretic Drugs Therapy Historical Market: Breakup by Application (USD Million), 2018-2022
7. Global Diuretic Drugs Therapy Market Forecast: Breakup by Application (USD Million), 2023-2028
8. Global Diuretic Drugs Therapy Historical Market: Breakup by Distribution Channel (USD Million), 2018-2022
9. Global Diuretic Drugs Therapy Market Forecast: Breakup by Distribution Channel (USD Million), 2023-2028
10. Global Diuretic Drugs Therapy Historical Market: Breakup by Region (USD Million), 2018-2022
11. Global Diuretic Drugs Therapy Market Forecast: Breakup by Region (USD Million), 2023-2028
12. North America Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
13. North America Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Europe Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
15. Europe Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Asia Pacific Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
17. Asia Pacific Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Latin America Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
19. Latin America Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Middle East and Africa Diuretic Drugs Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
21. Middle East and Africa Diuretic Drugs Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
22. Global Diuretic Drugs Therapy Market Structure
Key Questions Answered in the Report
The global diuretic drugs therapy market was supported by the thriving antihypertensive drugs industry, which attained a value of nearly USD 28 billion in 2020.
The antihypertensive drugs industry, which is aiding the growth of the global diuretic drugs therapy market, is projected to grow at a CAGR of 2% between 2021 and 2026.
The antihypertensive drugs market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 32 billion by 2026, thus, translating the growth of the global diuretic drugs therapy market.
The major drivers of the industry, such as the advancing pharmaceutical sector, increasing geriatric population, increasing sedentary lifestyles, and growing cases of high blood pressure and hypertension, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing investments in R&D activities and the advancements in the pharmaceutical sectors.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Thiazide diuretics local, loop diuretics, potassium-sparing diuretics, calcium sparing diuretics, osmotic diuretics, and low ceiling diuretics, among others are the significant diuretic drugs therapy products in the industry.
The major routes of administration include oral and intravenous.
The major applications of the product are hypertension, glaucoma, heart failure, and kidney stones, among others.
The major distribution channels of the product include hospital pharmacies, retail pharmacies, and online, among others.
The key players in the industry are Sanofi SA, Mylan N.V., Pfizer Inc., Cipla Ltd., and others.
Analyst Review
The global diuretic drugs therapy market is being supported by the growth of the antihypertensive drugs industry, which attained a value of nearly USD 28 billion in 2020 driven by the rising prevalence of hypertension and other lifestyle related diseases. Aided by the increasing R&D activities and the growing pharmaceutical sector, the antihypertensive drugs market is expected to witness a further growth in the forecast period of 2023-2028, expanding at a CAGR of 2% to reach a value of USD 32 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product, the diuretic drugs therapy industry can be segmented into thiazide diuretics local, loop diuretics, potassium-sparing diuretics, calcium sparing diuretics, osmotic diuretics, and low ceiling diuretics, among others. On the basis of distribution channels, the industry can be divided into hospital pharmacies, retail pharmacies, and online, among others. The major regional markets for diuretic drugs therapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sanofi SA, Mylan N.V., Pfizer Inc., and Cipla Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER